I think it is important for the longs to discuss what opportunities SUPG has and what hurdles need to be cleared. The Manuso clause has received other discussions, from the boards I watch and the general feeling is that it is very unigue. I was drawn to SUPG because of all the careless negative comments that were posted. I also like the fact the longs are starting to discuss when to take profits...both these usually indicate that the stock will move higher. Long term the focus on pipeline should begin soon with the company laying out the foundation and expectations. I'm equally impressed by the conservative approach SUPG has taken. Instead of giving a large piece of the shareholders equity away to top brass, they actually eliminated a position and sold off non core assets. Look internally at this company and there are some nice signs that they want to grow this company. If SUPG partners with a large pharma on any of it's pipeline,then my suggestion is to hold long term. They will minimize burn and big pharma doesn't enter into these deals with out DD.
Upper management is hungry. The fact that they keep presenting themselves to the investment community shows sign that there is no complacency in SUPG. I also like their location being in Dublin Norcal where some big Pharmas are around. Genentech is only a hop across the Bay Bridge and Orathrecin(for solid Tumors) can be an eye opener for the like of DNA. I like it and will buy on any pull back.